Myriad Genetics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US62855J1043
USD
7.33
0.31 (4.42%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'24
Dec'23
Dec'22
Dec'21
Jun'20
Jun'19
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
701.10
783.20
885.80
967.80
918.20
1,088.90
Shareholder's Funds
701.10
783.20
885.80
967.80
918.20
1,088.90
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
52.40
54.70
14.10
13.00
237.90
233.50
Secured Loans
52.40
54.70
14.10
13.00
237.90
233.50
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
32.70
1.60
3.50
35.80
26.60
82.60
Other Long Term Liabilities
122.8
268.9
294.2
241.4
254.5
225.5
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
30.20
26.80
27.90
23.50
28.50
Total Non-Current Liabilities
162.40
307.40
294.20
241.40
478.90
459.00
Current Liabilities
Trade Payables
32.30
25.80
28.80
29.60
21.70
33.30
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
30.20
26.80
27.90
23.50
28.50
Total Current Liabilities
164.10
155.90
137.20
204.30
147.00
117.80
Total Liabilities
1,027.60
1,246.50
1,317.20
1,413.50
1,544.10
1,665.70
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
282.00
300.50
296.50
232.20
209.90
169.20
Less: Accumulated Depreciation
109.60
119.90
109.20
106.90
106.90
111.90
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
172.40
180.60
187.30
125.30
103.00
57.30
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.90
7.60
62.30
59.00
37.00
54.90
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
4.20
7.80
8.00
8.30
0.00
0.00
Total Non-Current Assets
729.60
932.90
1,042.60
928.70
1,212.40
1,317.10
Current Assets Loans & Advances
Current Investments
0.00
8.80
58.00
81.40
54.10
43.70
Inventories
27.50
22.00
20.10
15.30
29.10
31.40
Sundry Debtors
121.20
114.30
101.60
91.30
68.10
133.90
Cash and Bank
111.00
133.30
58.90
258.40
163.70
93.20
Other Current Assets
259.70
278.40
238.60
446.40
317.90
306.90
Short Term Loans and Advances
0.00
0.00
0.00
0.00
2.90
4.70
Total Current Assets
298.00
313.60
274.60
484.80
331.70
348.60
Net Current Assets (Including Current Investments)
133.90
157.70
137.40
280.50
184.70
230.80
Total Current Assets Excluding Current Investments
298.00
313.60
274.60
484.80
331.70
348.60
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,027.60
1,246.50
1,317.20
1,413.50
1,544.10
1,665.70
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
52.40
54.70
14.10
13.00
237.90
233.50
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Dec 2024 is 2.86% vs 0.00% in Dec 2023

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Dec 2024 is -54.33% vs -8.60% in Dec 2023

stock-summary

Fixed Assets

YoY Growth in year ended Dec 2024 is -4.54% vs -3.58% in Dec 2023

stock-summary

Investments

YoY Growth in year ended Dec 2024 is -88.16% vs -87.80% in Dec 2023

stock-summary

Current Assets

YoY Growth in year ended Dec 2024 is -4.97% vs 14.20% in Dec 2023

Compare Balance Sheet Results of Myriad Genetics, Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(USD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
701.10
565.23
135.87
24.04%
Shareholder's Funds
701.10
565.23
135.87
24.04%
Minority Interest
0
0
0.00
0.00%
Long-Term Borrowings
52.40
1,937.72
-1,885.32
-97.30%
Secured Loans
52.40
1,937.72
-1,885.32
-97.30%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
32.70
22.46
10.24
45.59%
Other Long Term Liabilities
122.80
416.24
-293.44
-70.50%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
162.40
2,217.19
-2,054.79
-92.68%
Current Liabilities
Trade Payables
32.30
1,251.96
-1,219.66
-97.42%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
164.10
1,873.74
-1,709.64
-91.24%
Total Liabilities
1,027.60
4,656.16
-3,628.56
-77.93%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
282.00
1,430.09
-1,148.09
-80.28%
Less: Accumulated Depreciation
109.60
565.12
-455.52
-80.61%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
172.40
864.97
-692.57
-80.07%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0.90
6.11
-5.21
-85.27%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
4.20
93.05
-88.85
-95.49%
Total Non-Current Assets
729.60
2,635.14
-1,905.54
-72.31%
Current Assets Loans & Advances
Current Investments
0
0
0.00
0.00%
Inventories
27.50
1,131.88
-1,104.38
-97.57%
Sundry Debtors
121.20
690.24
-569.04
-82.44%
Cash and Bank
111.00
49.38
61.62
124.79%
Other Current Assets
259.70
1,873.40
-1,613.70
-86.14%
Short Term Loans and Advances
0
1.90
-1.90
-100.00%
Total Current Assets
298.00
2,021.02
-1,723.02
-85.25%
Net Current Assets (Including Current Investments)
133.90
147.28
-13.38
-9.08%
Total Current Assets Excluding Current Investments
298.00
2,021.02
-1,723.02
-85.25%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
1,027.60
4,656.16
-3,628.56
-77.93%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
52.40
1,937.72
-1,885.32
-97.30%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Borrowings 39.60 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.86% vs 0.00% in Dec 2023

Annual - Other Long Term Liabilities
Other Long Term Liabilities 122.80 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -54.33% vs -8.60% in Dec 2023

Annual - Fixed Assets
Fixed Assets 172.40 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -4.54% vs -3.58% in Dec 2023

Annual - Investments
Investments 0.90 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -88.16% vs -87.80% in Dec 2023

Annual - Current Assets
Current Assets 298.00 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is -4.97% vs 14.20% in Dec 2023